Thrombophilia identified as a risk factor for thrombogenesis in cancer patients

Thrombophilia identified as a risk factor for thrombogenesis in cancer patients

Aim: to assess a rate and range of genetic and acquired thrombophilia in onco-gynecologic patients with ovarian cancer, uterine corpus cancer and cervical cancer.Materials and Мethods. A prospective controlled cohort non-randomized interventional study was conducted: within the years 2014 to 2020, t...

Full description

Bibliographic Details
Main Authors: A. V. Vorobev, A. D. Makatsariya, V. O. Bitsadze, A. G. Solopova, D. A. Ponomarev
Format: Article
Language:Russian
Published: IRBIS LLC 2021-07-01
Series:Акушерство, гинекология и репродукция
Subjects:
genetic and acquired thrombophilia
thrombotic complications
anticoagulant therapy
circulating antiphospholipid antibodies
apa
thrombosis risk factors
Online Access:https://www.gynecology.su/jour/article/view/1003

Internet

https://www.gynecology.su/jour/article/view/1003

Similar Items